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Identifying the MAGUK Protein Carma-1
as a Central Regulator of Humoral Immune Responses
and Atopy by Genome-Wide Mouse Mutagenesis
Introduction
Antigen receptors on lymphocytes exhibit remarkable
plasticity to trigger different and opposing cellular re-
sponses. In lymphocytes that bind components of our
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tolerated by less well-understood mechanisms. By con-Genetics Laboratory and
trast, pathogenic foreign antigens act through the sameMedical Genome Centre
receptors to elicit various modes of humoral or cell-John Curtin School of Medical Research
mediated immunity by stimulating cell proliferation andAustralian National University
differentiation into various types of effector cells, suchCanberra ACT 2601
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of antigen recognition such as elevation of intracellular
calcium and activation of protein kinase C (PKC). The
central role of these initiating components is demon-
strated by the severe lymphocyte deficiencies in miceSummary
or humans with null mutations in these molecules (see
reviews referenced above). The signal-initiating compo-In a genome-wide ENU mouse mutagenesis screen a
nents then recruit and activate a branching array of
recessive mouse mutation, unmodulated, was isolated
proteins such as calcium-activated enzymes, Ras and
with profound defects in humoral immune responses, PKC in B cells, or PKC in T cells, which in turn trigger
selective deficits in B cell activation by antigen recep- a suite of downstream signaling cascades that terminate
tors and T cell costimulation by CD28, and gradual in the lymphocyte nucleus where they regulate gene
development of atopic dermatitis with hyper-IgE. Mu- expression.
tant B cells are specifically defective in forming con- Differential triggering of immunity or tolerance by
nections between antigen receptors and two key sig- antigen receptors is poorly understood but appears to
naling pathways for immunogenic responses, NF-B arise in large part through differential coupling to differ-
and JNK, but signal normally to calcium, NFAT, and ent intracellular signal transduction relays (DeFranco,
ERK. The mutation alters a conserved leucine in the 1997; Goodnow, 2001; Leitenberg and Bottomly, 1999;
coiled-coil domain of CARMA-1/CARD11, a member Schwartz, 2002). In mature B cells, immunogenic or tol-
of the MAGUK protein family implicated in organizing erogenic antigens activate the ERK MAP kinase to phos-
multimolecular signaling complexes. These results de- phorylate nuclear transcription factors, promoting B cell
fine Carma-1 as a key regulator of the plasticity in proliferation to immunogenic antigens (Richards et al.,
antigen receptor signaling that underpins opposing 2001) and mediating some tolerogenic effects of self-
mechanisms of immunity and tolerance. antigens (Glynne et al., 2000; Healy et al., 1997). Immu-
nogenic and tolerogenic B cell responses also share in
common an increase in intracellular calcium, albeit at
lower amplitude in tolerant B cells, triggering calcineurin*Correspondence: chris.goodnow@anu.edu.au
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to dephosphorylate the transcription factor NFAT and of genome-wide chemical mutagenesis and phenotype-
specific screening that has been so successfully usedactivate its movement into the nucleus where it triggers
a subset of immunogenic or tolerogenic genes (Glynne to analyze development in invertebrates. Here we de-
scribe a recessive mouse mutation resulting from ouret al., 2000; Healy et al., 1997). Calcium signals also
mediate tolerance by clonal deletion through activating initial test of this strategy, bearing a point mutation in the
mouse ortholog of CARMA-1, a member of the MAGUKthe proapoptotic Bcl-2 inhibitor, Bim (Bouillet et al.,
2002). The chief distinction between B cell immunogenic family of proteins (Bertin et al., 2001; Fanning and Ander-
son, 1999; Gaide et al., 2001). Based on the severe,responses to foreign antigens and tolerogenic re-
sponses to self-antigens (clonal anergy) is, in the latter, selective defects in immune responses and immuno-
genic signaling in B and T cells carrying this mutation,a selective uncoupling of the BCR from activating the
NF-B and JNK cascades (Glynne et al., 2000; Healy et and on the relationship of the mutant protein to organiz-
ers of synapses and signalosomes in invertebrates, oural., 1997). The NF-B transcription factors, p50/c-Rel
and p50/Rel-A, activate key lymphocyte growth and sur- findings define a central role for this protein as regulator
of immune responses to antigen.vival genes and are essential for immunogenic responses
to antigen in B and T cells (Gerondakis et al., 1999). NF-
B moves to the nucleus following phosphorylation and Results
ubiquitin-mediated degradation of the cytoplasmic in-
hibitors of B (IBs) by IB kinase (IKK; Li and Verma, Derivation of unmodulated Mutant Mouse Strain
2002). Calcium and calcineurin are required for BCR and Identification of Mutated Gene
activation of these events and for JNK activation (Dol- A library of mice with random, genome-wide point muta-
metsch et al., 1997; Hashimoto et al., 1998; Healy et al., tions was generated by treating C57BL/6 male mice with
1997; Venkataraman et al., 1995), so that they require the the chemical mutagen, ethylnitrosourea (ENU; Hitotsu-
initiating calcium-activating signalosome components, machi et al., 1985). Individual first generation male off-
Btk (Bajpai et al., 2000; Petro et al., 2000), BLNK (Tan spring were used as founders of inbreeding pedigrees
et al., 2001), and PLC2 (Petro and Khan, 2001). PKC by breeding with a wild-type female and then with sev-
(Saijo et al., 2002; Su et al., 2002) and the adaptor protein eral daughters. Approximately 20 third generation off-
Bcl10 (Ruland et al., 2001) are not required for the cal- spring in 185 pedigrees were screened for blood lym-
cium response but are selectively required for BCR sig- phocyte abnormalities by flow cytometry. Several mice
nals to IKK/IB/NF-B. It is not understood how these in one pedigree exhibited an unusually high level of
proteins coordinately activate NF-B or JNK during im- surface IgM antigen receptors on circulating IgDB cells
munogenic BCR signaling or how these connections (Figure 1A). This phenotype was inherited as a simple,
are selectively diminished for tolerogenic signaling in fully penetrant recessive trait in the progeny and was
anergic B cells or B1 cells (Wong et al., 2002), although characterized by 100% increased mean IgM and 50%
qualitative and quantitative changes in intracellular cal- higher expression of CD21 (Figure 1A). Because surface
cium play a part (Dolmetsch et al., 1997). IgM is normally modulated to lower levels on many ma-
Similar plasticity in antigen receptor signaling occurs ture recirculating B cells, relative to transitional B cells,
the mutant strain was named unmodulated. This highin T cells and is also poorly understood. T cell tolero-
genic responses to antigen are characterized by re- surface IgM phenotype is reminiscent of previously de-
scribed mutations in BCR signaling (Fruman et al., 2000;duced calcium signaling (Jenkins et al., 1987; LaSalle
et al., 1992; Sloan-Lancaster and Allen, 1996) and dimin- Turner and Billadeau, 2002).
The chromosomal location of unmodulated was ini-ished JNK and NF-B activation while continuing to
signal to NFAT (Guerder et al., 2001; Li et al., 1996; tially mapped to a 12cM region of chromosome 5 in an
F2 intercross between unmodulated C57BL/6 homozy-Sundstedt et al., 1996). The ERK and JNK pathways
cooperatively activate the Fos/Jun nuclear transcription gotes and the NOD.H-2k strain. Since no known compo-
nents of BCR signaling were encoded in this region, wefactor, AP-1, during immunogenic signaling in T cells
(Chang and Karin, 2001). Tolerogenic signaling through continued mapping via an F3 and F4 intercross, localiz-
ing the defect to a 1 Mb region (Figure 1B). This regionNFAT in the absence of AP-1 triggers a distinct set
of T cell anergy genes and brings about a tolerogenic contains 17 predicted genes. Resequencing of mRNA
and exons in genomic DNA revealed a single T→A nucle-response, and null mutations in NFAT result in defective
anergy induction, excessive T cell immune responses, otide substitution in a gene identified as the mouse
homolog of CARMA-1/CARD11 (Bertin et al., 2001;and immunopathology (Macian et al., 2002). The bio-
chemical response to antigen in T cells that have differ- Gaide et al., 2001) by BLAST analysis. The mutation
resulted in a Leu→Gln codon substitution (Figure 1C).entiated to Th2 cells shares some of the same changes in
TCR signaling, with intact NFAT signaling but diminished This residue lies within a segment predicted by the
COILScan program (Lupas et al., 1991) to form a coiled-JNK and NF-B activation (Dorado et al., 1998; Lederer
et al., 1996; Yang et al., 1998). Suboptimal TCR stimuli coil (CC) domain and is a conserved leucine in the hep-
tad repeats of the predicted -helical coil (Figure 1D).and failure to activate JNK and NF-B selectively elicit
Th2-type responses (Aronica et al., 1999; Dong et al., Western blotting with an antiserum to Carma-1 revealed
normal levels of the protein in mutant B cells (Figure2000; Hilliard et al., 2002; Leitenberg and Bottomly, 1999;
Sloan-Lancaster and Allen, 1996; Yang et al., 1998). It is 1E). The change to polar glutamine from nonpolar leu-
cine would be predicted to disrupt the CC structure (seenot known how these different T cell responses to anti-
gen are achieved. Supplemental Figure S1 at http://www.immunity.com/
cgi/content/full/18/6/751/DC1) and interfere with pro-To identify key regulators of immunogenic and tolero-
genic responses, we set out to apply in mice the strategy tein pairing.
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Figure 1. Identification of unmodulated Strain with Substitution in Carma-1
(A) Blood B cell phenotype identifying unmodulated mutant mice. Peripheral blood cells stained for surface IgM and IgD with percentage of
cells in quadrants indicated. Lower panel shows mean fluorescence intensity (MFI) of CD21 and IgM of a group of homozygous (un/un) and
heterozygous (un/) unmodulated mice. No differences were detectable between heterozygotes and wild-type animals (/, data not shown).
(B) High-resolution haplotype matrix representing a part of mouse chromosome 5 (the double-headed arrow denotes the maximum nonrecombi-
nant interval). Black squares indicate C57BL/6 homozygotes; white squares indicate C57BL/6 and NOD.H-2k heterozygotes. Map positions
refer to public mouse genome assembly (http://mouse.ensembl.org/). Carma1 L298Q is an allele-specific PCR marker differentiating T→A
mutation and used for PCR screening of mutants.
(C) Resequencing traces of Carma-1 mRNA showing point-mutation and resulting codon substitution in coiled-coil domain.
(D) Alignment of partial amino acid sequences of CC domain in mouse and human Carma proteins. Residues that are conserved in 100% of
analyzed proteins are boxed and shaded. The arrowhead indicates mutated leucine in unmodulated animals.
(E) Western blot for Carma-1 in purified B cells stimulated with anti-IgM for the indicated times.
Lymphocyte Development in unmodulated Mice discernable effect of the mutation on T cell develop-
mental subsets in the thymus or on the numbers ofLymphocyte development and peripheral subsets were
analyzed in unmodulated mice by flow cytometry. In the circulating CD4 or CD8 T cells in lymph nodes or spleen,
but there was an increased cellularity in lymph nodesbone marrow, no significant difference in the frequency
of pre-B cells or immature B cells could be detected (Figures 2B and 2C and Supplemental Figure S2). The
number of IgD mature follicular B cells in the spleenbetween unmodulated homozygotes (un/un) and het-
erozygous (un/) or wild-type (/) controls (Figure 2A was also not different (Supplemental Figure S2). The
frequency of T and B cells in lymph nodes and spleenand Supplemental Figure S2 at http://www.immunity.
com/cgi/content/full/18/6/751/DC1). There was also no was normal, although there was an overall increase in
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different (Figure 3A). We then tested whether there were
deficits in B cell antibody responses to T cell-indepen-
dent type 2 antigen. Compared to wild-type control
mice, unmodulated animals showed little increase in
serum IgM and no increase in serum IgG3 titers to the
DNP hapten following immunization with DNP-Ficoll
(Figure 3B). There was also a dramatic decrease in the
primary antibody response to immunization with the
T cell-dependent antigen, chicken  globulin (CGG; Fig-
ure 3B), and poor formation of germinal centers (data
not shown). When mice are immunized with the strongly
immunogenic mixture of T cell-dependent antigens,
alum-precipitated DNP-CGG, and heat-killed Bordetella
pertussis, the response to CGG is normally skewed to
the Th2 subtype of IgG1 whereas the antibodies to the
bacterial antigen are primarily IgG2a associated with
the Th1-type response (Toellner et al., 1998). In unmodu-
lated mice, the IgG1 response to CGG was lower but
not absent, whereas there was no detectable IgG2a
response to pertussis organisms 16 days after combined
immunization (Figure 3C). This suggests that the point
mutation in Carma-1 cripples Th1-type antibody re-
sponses more severely than Th2-type responses.
Selective B Cell Response Deficits
The defects in the antibody response were further delin-
eated by measuring unmodulated B cell responses to
key B cell activating stimuli in vitro. Crosslinking B cell
antigen receptors with antibodies to IgM stimulates vig-
orous cell division in wild-type B cells within 48 hr, but
Figure 2. Flow Cytometric Analyses of Lymphoid System in Wild- this response was greatly reduced in unmodulated B
Type and unmodulated Mice cells (Figure 4A). When splenic B cells were labeled with
Development of lymphocytes in primary and secondary lymphoid CFSE and activated with anti-IgM antibodies, mutant B
organs; bone marrow (A), thymus (B), spleen (C, D, E, and G), and cells were intrinsically poorer in survival, and very few
peritoneal cavity (F). Numbers indicate the percentage of gated proceeded through more than one cell division by 72
population of lymphocytes. Only B220 positive splenocytes are ana-
hr, while wild-type B cells in the same culture dividedlyzed in (E). Dashed lines indicate the peak intensity of CD21 in wild-
extensively (Figure 4B, upper). By contrast, the Carma-1type controls (G). Absolute numbers of different cell types are given
mutant B cells proliferated normally to bacterial lipopoly-in the Supplemental Data at http://www.immunity.com/cgi/content/
full/18/6/751/DC1. saccharide (LPS), demonstrating that the mutation se-
lectively diminishes coupling of the BCR but not Toll-
like receptor 4 (TLR4) to mitogenic signaling (Figure 4B,lymph node cell numbers (Figure 2D and Supplemental
lower). No differences in LPS dose response were de-Figure S2). The chief phenotypic difference in the IgD
tectable (data not shown). Proliferation induced by anti-cells was a shift to higher levels of surface IgM and
body to the CD40 receptor, which mimics an importantCD21 (Figure 2G). The level of CD23 on follicular B cells
helper T cell signal, was also reduced (Figure 4A). Addi-was also elevated 100% (p  0.001, Figure 2E). In the
tion of the T cell-derived cytokine IL-4 improved but didperitoneal cavity, the B1 cell subset (IgM CD5
not fully restore proliferation to anti-IgM or anti-CD40CD23Mac1) was nearly absent although the number
(Figure 4A).of B2 cells was unaffected (Figure 2F).
The initial phase of B cell activation is marked byConstruction of competitive mixed bone marrow radi-
upregulation of cell-cell interaction markers and cyto-ation chimeras, by reconstituting lethally irradiated mice
kine receptors in response to different intracellular sig-with an equal amount of B6-Ly5a wild-type and B6-
nals. The CD25 protein encodes the  subunit of theLy5b unmodulated bone marrow, confirmed that the
receptor for IL-2 and is induced through a pathway thatCarma-1 mutation does not affect B or T cell develop-
requires signaling through NF-B c-Rel (Grumont et al.,ment or peripheral B or T cell numbers and their capacity
1998). Relatively little CD25 was induced on unmodu-to accumulate. These experiments also showed that the
lated B cells when stimulated by B cell antigen receptorhigher expression of IgM and absence of peritoneal B1
crosslinking, but this protein was induced normallycells are limited to cells carrying the mutation and thus
when the mutant cells were stimulated by LPS (Figurereflect a B cell-intrinsic requirement for Carma-1 (Sup-
4C, upper). A similar selective reduction in responseplemental Figures S3 and S4).
to BCR but not TLR4 stimuli was observed for CD69
induction (data not shown). BCR signaling and responseDiminished Antibody Responses
nevertheless appeared normal as measured by induc-Sera from unmodulated mice had 50% less IgM (p 	
tion of the T cell stimulating protein, CD86 (Figure 4C,0.01) and 90% less IgG3 (p 	 0.003) than wild-type
control mice. Serum IgG levels were not significantly lower). Stimulation with a combination of phorbol ester,
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Figure 3. Defective TI and TD Antibody Responses in unmodulated Mice
(A) Basal serum antibody levels in wild-type (/) and mutant (un/un) mice. Each symbol represents one mouse. Horizontal bars are drawn
through the median value of each group.
(B) DNP-specific antibody levels 9 and 8 days after soluble DNP-Ficoll and alum-precipitated DNP-CGG immunization, respectively.
(C) Bordetella pertussis-specific and CGG-specific IgG2a and IgG1 antibody responses 16 days after combined alum-precipitated CGG plus
B. pertussis immunization.
Figure 4. Selective Defects in In Vitro B Cell Responses
(A) DNA synthesis by splenic B cells cultured 48 hr with the indicated stimuli. Mean 
SD of triplicate samples is shown.
(B) Division of CFSE-labeled wild-type and mutant B cells stimulated with anti-IgM and LPS for 72 hr. Shaded histogram shows undivided
cells in parallel cultures with IL-4 alone.
(C) Induction of CD25 and CD86 in pure B cells after 16 hr stimulation. Wild-type, shaded histograms; mutant, open histograms.
Immunity
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Figure 5. Point Mutation in Carma-1 Impairs NF-B and JNK Activation
(A) Protein tyrosine phosphorylation in purified spleen B cells after stimulation with anti-IgM for the times shown.
(B) Elevation of intracellular calcium, measured by Indo-1 fluorescence after stimulation with anti-IgM (arrow).
(C) Lymph node B cells prestained with CT-FITC were stimulated with anti- light chain antibodies. Localization of raft and BCR were analyzed
by confocal microscopy 10 min after stimulation.
(D) Phosphorylation of ERK and JNK measured in purified B cells by Western blotting with anti-phosphoERK1/2 or anti-phosphoJNK antibodies.
Blots were reprobed for -actin to confirm equal loading. Shown below is densitometric intensity of phosphoJNK relative to unstimulated
cells and corrected for -actin signal. Results are representative of three experiments.
(E) BCR-induced degradation of IB measured by Western blotting. The densitometric intensity of IB was analyzed as in (D). Results are
representative of three experiments.
(F) JNK and Bcl10 phosphorylation in purified B cells following stimulation with PMA and ionomycin. Bcl10, approximately 34 kDa, unfilled
arrowhead; PhosphoBcl10, approximately 40 kDa, filled arrowhead. Equivalent cell stimulations were confirmed by Western blotting for
phophoERK1/2.
phorbol 12-myristate 12-acetate (PMA), and ionomycin tant, key signaling events were examined. Crosslinking
IgM receptors induced a normal pattern and intensity ofto mimic downstream events in BCR signaling also elic-
ited a diminished CD25 response in unmodulated B cells tyrosine phosphorylation on the Ig/ receptor subunits
and other cellular proteins (Figure 5A), and a normal(Figure 4C). These results are consistent with a selective
defect in B cell response to antigen. amplitude and kinetics of intracellular calcium elevation
(Figure 5B). Consistent with the normal intracellular cal-
cium response, mutant B cells exhibited a normal de-Point Mutation in Carma-1 Selectively Impairs
NF-B and JNK Activation phosphorylation and cytoplasmic/nuclear translocation
of NFAT (data not shown). Crosslinking BCRs inducedTo identify BCR signaling impairments responsible for
the observed immunological defects in the Carma-1 mu- grossly normal cap structures with cocapping of the
Carma-1 Regulates the Quality of Immune Responses
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Figure 6. Selective Immune Response De-
fects in unmodulated T Cells
(A) DNA synthesis after 48 hr in unfraction-
ated splenocytes from wild-type (filled sym-
bols) and mutant (unfilled symbols) mice
stimulated with the indicated concentrations
of plate-bound anti-TCR in the presence (tri-
angles) or absence (circles) of anti-CD28.
(B) Division of CFSE-labeled wild-type and
mutant CD4 T cells after 72 hr in unfraction-
ated spleen cells stimulated with 10 g/ml
anti-TCR cultured separately (left) or with mu-
tant and wild-type mixed 1:1 and cocultured
(right). Dashed lines indicate modal CFSE in
undivided cells.
(C) Induction of CD25 after 24 hr on CD4
T cells stimulated as indicated (unshaded) or
cultured without stimulation (shaded). Num-
bers represent MFI of CD25 on stimulated
cells.
(D) DNA synthesis in purified splenic T cells
stimulated with the indicated concentrations
of plate-bound anti-TCR (filled, /; open,
un/un). Mean 
SD is shown for three mice of
each genotype.
lipid raft marker, GM1 sphingolipid (Figure 5C). Activation division in CFSE-labeled cells, wild-type T cells proceed
through multiple cell divisions in response to optimalof two key MAP kinases, ERK and JNK, were analyzed
by Western blotting with anti-sera specific for phosphor- concentrations of immobilized anti-TCR antibody (Fig-
ure 6B). In these cultures of unfractionated spleen cells,ylated forms. The ERK MAP kinase cascade was acti-
vated normally by BCR crosslinking or by the pharmaco- the progression through multiple cell divisions depends
on costimulatory signals from the B7 costimulatory li-logic mimics PMA and ionomycin (Figure 5D). In
contrast, JNK phosphorylation was reduced in magni- gands for CD28 expressed on B cells and dendritic cells
(Lucas et al., 1995; Sperling et al., 1996; Wells et al.,tude, especially at later time points, after both BCR or
PMA/ionomycin-mediated induction (Figure 5D and 5F). 1997). When this source of costimulation is blocked by
addition of the soluble receptor for B7, CTLA4-Ig, or bySignaling to the NF-B pathway was measured by
degradation of IB. BCR engagement initiated a rapid T cell CD28 deficiency, the T cells begin to divide nor-
mally but fail to proceed through multiple divisions (opreduction of IB to 40% of initial level within 30 min in
control B cells, whereas little degradation was induced cit). Unmodulated T cells exhibited a defective response
in these cultures that was comparable in severity to thatin unmodulated B cells, indicating that antigen receptor
signaling is partially uncoupled from NF-B activation described for CD28-deficient or B7-blocked cells, in that
they began DNA synthesis in response to anti-TCR (Fig-(Figure 5E). BCR or PMA/ionomycin stimulation induced
phosphorylation of Bcl10, an essential protein for anti- ure 6A) but few divided more than one or two times
(Figure 6B). This defect was intrinsic to the mutant T cellsgen receptor activation of NF-B known to interact with
Carma-1, as measured by the phosphorylation-medi- based on the fact that they exhibited the same response
deficit when cultured alone (Figure 6B, left panels) orated retardation in the electrophoretic mobility of Bcl10
(Gaide et al., 2001; Ruland et al., 2001). This response cocultured with wild-type cells (Figure 6B, right panel).
was undetectable in unmodulated B cells (Figure 5F). Moreover, whereas DNA synthesis to suboptimal TCR
Thus, B cells with a Carma-1 mutation display a selec- stimulation is enhanced in wild-type T cells by anti-CD28
tive, partial deficit in antigen receptor coupling to the antibody stimulation, the mutant cells were refractory to
JNK and NF-B signaling pathways, while retaining nor- further enhancement by CD28 costimulation (Figure 6A).
mal signaling to the ERK and calcium/NFAT pathways. A similar selective defect in CD28 costimulation was
apparent by measuring cell surface induction of the IL-2
receptor subunit, CD25 (Figure 6C). TCR stimulationDefects in Responsiveness of unmodulated T Cells
The poor antibody response of Carma-1 mutant mice alone elicits only low CD25 expression on a fraction of
wild-type or mutant T cells. Addition of agonistic anti-to T cell-dependent immunization (Figure 3B) suggests
that T cell responses to antigen may also be affected body to CD28 greatly increased the frequency and levels
of CD25 on wild-type T cells but had only a modestby the mutation. To examine this, T cell activation re-
sponses were measured in vitro. In contrast to the se- effect on mutant T cells. TCR-induced expression of
CD25 is mediated by a pathway involving NF-B c-Relvere proliferative defect in B cells, unmodulated T cells
enlarged and engaged in DNA synthesis normally during (Liou et al., 1999). PMA and CD28 costimulation can be
used to mimic CD3/CD28 costimulation leading to JNKthe first 48 hr of culture when stimulated by crosslinking
their T cell antigen receptors (Figure 6A). By tracing cell activation (Su et al., 1994), and CD28 enhances PMA-
Immunity
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Figure 7. Spontaneous Atopy in unmodu-
lated Mice
(A) Serum IgE concentration in mice of the
indicated genotypes and age groups.
(B) Representative histology of wild-type and
mutant mouse skin with atopic dermatitis,
stained with hematoxylin and eosin (H&E) or
Alcian blue to reveal mast cells (arrowhead).
induced degradation of IB (Alkalay et al., 1995). Strik- ressing to dermatitis of the ear and neck. Histologically,
ingly, the capacity of CD28 to induce CD25 expression the inflamed regions of skin exhibit hyperkeratosis, ex-
in combination with PMA was completely abolished in tensive mast cell infiltrates, mononuclear cells, and oc-
unmodulated T cells (Figure 6C). DNA synthesis in re- casional eosinophils (Figure 7B). This spontaneous
sponse to TCR stimulation alone, in purified T cell cul- atopic disorder was also observed in mice with C57BL/
tures lacking cells with B7 ligands, was comparable in 6 x NOD.H-2k F2 hybrid background as part of the map-
mutant and wild-type T cells (Figure 6D). Collectively, ping cross and again was strictly correlated with homo-
these findings indicate that the Carma-1 point mutation zygosity for the Carma-1 mutation.
results in a severe and selective deficit in CD28 costimu-
lation in T cells.
Discussion
Spontaneous Atopy and Dermatitis in Aging
By developing a strategy of genome-wide mutagenesisMutant Homozygous Mice
and screening for recessive immunological defects, weWhile young unmodulated mice are healthy and have
have isolated a unique mouse mutation that definesnormal serum antibody levels other than the reduction
the recently discovered Carma-1 protein as a centralin serum IgM and IgG3 noted above, the majority of
regulator of the quality of lymphocyte responses to anti-homozygous mutant mice but none of their un/ or/
gen. We show that Carma-1 is critical for B cell immuno-littermates begin to develop high serum levels of IgE,
genic responses to antigen in vivo and in vitro, and forteary eyes, and erythematous ears at 10–20 weeks of
age (Figure 7A). Their ears become intensely itchy, prog- establishing the immunogenic quality of BCR signals
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involving NF-B and JNK, as compared to BCR signals or pathways can compensate for its function in normal
T lymphocytes.to calcium, NFAT, and ERK that are tolerogenic on their
own and do not require Carma-1. In resting primary The role of Carma-1 in determining signal quality in
lymphocytes is especially illuminated by comparing theT cells, we demonstrate that Carma-1 plays a critical role
in mediating the effects of CD28, both for upregulation of functional effects of the unmodulated point mutation
with the null allele engineered by Hara et al. (2003 [thisIL-2 receptors and for promoting sustained rounds of
cell division. The patterns of antibody made in the mu- issue of Immunity]). The point mutation preserves
Carma-1 protein levels but is likely to disrupt the struc-tant animals reveal that Carma-1 plays a critical role in
regulating the quality of humoral immunity and atopy. ture of the CC domain (see Supplemental Figure S1 at
http://www.immunity.com/cgi/content/full/18/6/751/Carma-1 is one of three related MAGUK proteins re-
cently identified in database searches for proteins con- DC1). CC domains occur in diverse proteins, where they
promote dimerization or multimerization by formingtaining homology to the CARD domain (Bertin et al.,
2001; Gaide et al., 2001; McAllister-Lucas et al., 2001). two-, three-, or four-stranded bundles of interwound 
helices (Burkhard et al., 2001). The simplest hypothesisCARD domains are specific protein dimerization do-
mains found in many proteins that activate apoptosis to be drawn is that the mutation prevents Carma-1 from
assembling into higher order complexes with itself oror NF-B (Bertin et al., 2001). Like the much larger family
of MAGUK proteins (Fanning and Anderson, 1999), each with other CC partners, but this will require future investi-
gation. It is striking that the CC point mutation onlyof the Carma proteins contains a PDZ, SH3, and GUK
domain, but they are distinguished by the presence of partially interferes with IB degradation whereas it
completely blocks Bcl10 phosphorylation (Figures 5Ethe CARD domain and the CC domain. Another homolo-
gous protein is CARD-9, which contains a similar CARD and 5F). The CC domain thus appears to be essential
for coordinating or activating an undefined Bcl10 serine-and CC domain but lacks the MAGUK elements (Bertin
et al., 2000). CARD-9 and all of the CARD-MAGUK family threonine kinase; potential candidates include one of
the PKCs or MAP3Ks such as Cot, NIK, or HPK1 whichmembers have been shown in overexpression studies
to interact with Bcl10 via the CARD domain, and when have all been implicated in NF-B activation (Kane et
al., 2002). In response to antigen receptor engagement,overexpressed each is able to activate NF-B in a pro-
cess that depends on Bcl10 and IKK (Bertin et al., 2000, B cells with the point mutation or the null allele respond
poorly, indicating that the CC domain of Carma-1 plays2001; Gaide et al., 2001; McAllister-Lucas et al., 2001).
The CARD and CC domains are sufficient for optimal NF- a critical role in BCR signaling for activation. This conclu-
sion is reinforced by the close similarities in B1 cellB activation in overexpression studies. Overexpres-
sion of the related Carma-3/Bimp-1 protein lacking the deficiency and high IgM expression observed here and
in the knockout animals examined by Hara et al. (2003).CARD domain blocks TCR-induced NF-B activation in
T hybridoma cells (McAllister-Lucas et al., 2001). While The CC domain mutation has no effect on B cell prolifer-
ation to LPS, however, whereas this response is bluntedCarma-2 and -3 do not appear to be expressed in
hematopoietic cells, CARD-9 and Carma-1 mRNA are in Carma-1 null B cells. The remaining domains in the
point-mutated protein therefore appear to be sufficientprominent in spleen and peripheral blood lymphocytes,
suggesting that both may serve roles in antigen/Bcl10- for supporting TLR4 responses, perhaps because the
CARD domain alone helps to activate the CARD-bearingmediated NF-B activation in B or T cells.
During the preparation of this manuscript, several kinase, RIP2, which is involved in TLR4 but not BCR
proliferation (Chin et al., 2002; Kobayashi et al., 2002).publications have defined a role for Carma-1 in TCR
signaling in Jurkat T lymphoma cells. A mutagenized In contrast with the effects of the CC domain mutation
on BCR proliferation, TCR-induced entry into cell cycleJurkat subline that has lost Carma-1 is no longer able
to activate NF-B or induce IL-2 production in response is unaffected by the point mutation whereas it is almost
completely blocked by the null mutation (Hara et al.,to TCR-CD28 stimulation, whereas calcium, ERK, NFAT,
AP-1, and JNK responses are intact (Wang et al., 2002). 2003). The other domains of Carma-1 are therefore suffi-
cient to mediate TCR signaling to NF-B for the initialSimilar effects on TCRCD28 activation of NF-B result
from RNAi knockdown of Carma-1 in Jurkat cells (Pom- response. The CC domain is nevertheless critical for the
augmenting and survival effects of CD28 costimulation.erantz et al., 2002). Carma-1 accumulates with the TCR
and coalesced raft structures with a 10–20 min time The CC domain may be required for CD28 to cluster
lipid rafts, PKC, or a number of MAP3K’s that are impli-course after TCR stimulation and, like the earlier studies
with Carma-3 (McAllister-Lucas et al., 2001), overex- cated in CD28 signaling for NF-B and JNK (Kane et al.,
2002).pression in Jurkat cells of Carma-1 with a mutated CARD
domain blocks NF-B, JNK, and IL-2 production but The incomplete loss of T cell immunogenic responses
in the point mutant may explain the hyper-IgE disorder.does not affect calcium or ERK responses (Gaide et al.,
2002; Pomerantz et al., 2002). The phenotype of the The preferential extinction of IgG2a over IgG1 responses
during acute immunization in unmodulated is consistentunmodulated mouse mutant defines Carma-1 as a criti-
cal regulator of the quality of B and T cell responses to with similar selective deficits in Th1 responses and the
shift toward Th2 responses described in mice with par-antigen in vivo and in vitro. The profound and selective
deficits in B cell subsets, depressed responses to anti- tial defects in NF-B activation, due to overexpression
of a nondegradable IB (Aronica et al., 1999; Seethara-gen and BCR crosslinking but not to LPS, and the dem-
onstration that these are cell-intrinsic deficits reveals man et al., 1999) or deficiency of the c-Rel NF-B subunit
(Hilliard et al., 2002). Exaggeration of Th2 cytokine pro-Carma-1 to be an essential regulator of B cell antigen
responses. The defects in CD28 response in unmodu- duction also occurs when T cell activation of JNK is
defective (Dong et al., 2000; Yang et al., 1998). Subopti-lated T cells rule out the possibility that other proteins
Immunity
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10% ethanol, citrate buffer (pH 5.0). After 8 weeks, the treated micemal TCR signaling tends to promote Th2 differentiation
were mated with C57BL/6 females. Individual G1 progeny were bred(Leitenberg and Bottomly, 1999). However, in none of
with C57BL/6 females and then with 4–6 G2 daughters. Unmodu-these instances is spontaneous severe atopy described,
lated was mapped in F2 intercrosses between mutant C57BL/6 x
raising the possibility that the combined deficits in NF- NOD.H-2k F1 mice using the MIT microsatellite panel (http://www-
B and JNK that result from Carma-1 defects create a genome.wi.mit.edu/). For fine mapping in F3 and F4 animals public
severe dysregulation of the normal Th2/Th1 balance. and novel (MGC) microsatellite markers were used (see Supplemen-
tal Data at http://www.immunity.com/cgi/content/full/18/6/751/MAGUK proteins are examples of an emerging class of
DC1). Candidate mRNAs and exons were amplified in 300–800 bpproteins that organize submicron-sized supramolecular
fragments by PCR from spleen cDNA or genomic DNA and rese-complexes and are hypothesized to determine signal
quenced by cycle sequencing with big dye terminator kit (Applied
sensitivity or quality (Fanning and Anderson, 1999; Biosystems). A mutagenically separated (MS)-PCR assay (Rust et
Sheng and Sala, 2001). In neurological synapses and al., 1993) was established to identify the unmodulated carma-1 point
neuromuscular junctions, the MAGUK proteins PSD95 mutation from ear punch samples for propagation and analysis.
and Disks-large bind and cluster together receptors,
signal-transducing molecules, channels, and cytoskele- Flow Cytometry and Serum Antibody Responses
ton (Sheng and Sala, 2001). Our data indicates that Lymphoid cell suspensions were prepared, stained, and analyzed
Carma-1 indeed determines the quality of signals and by flow cytometry as previously described (Miosge et al., 2002). Mice
were immunized between 9 and 12 weeks of age by intraperitonealcellular responses elicited by antigen in B and T cells
injection. For TI-2 immune responses mice received 25 g DNP-and thus represents clear evidence for the hypothesized
Ficoll (Biosearch Technology) in PBS, and for TD responses, 50role of MAGUKs as modulators of signal quality. In B
g DNP-CGG (Biosearch Technology) precipitated in alum with or
and T cells, it is likely to do this not as a simple adaptor without 5  108 whole killed Bordetella pertussis (Lee Labs, Becton
for Bcl10 but by coordinating a signalplex (Montell, 1999) Dickinson). For ELISA, hapten-specific or total antibodies in serially
comprising some or all of the essential enzymes for diluted sera were adsorbed by plate-coated DNP-BSA (Biosearch
Technology), CGG, sonicated B. pertussis, or sheep anti-mouse BCR-, CD40-, or CD28-induced activation of NF-B and
light chain (Southern Biotechnology), respectively. Bound immuno-JNK, such as BTK, BLNK, Vav, PLC, calcineurin, PKC,
globulins were detected by alkaline phosphatase-conjugated detec-Cot, Akt, NIK, and Bcl10 (Bajpai et al., 2000; Kane et al.,
tion antibodies to specific mouse isotypes (Southern Biotechnology)2002; Petro and Khan, 2001; Petro et al., 2000; Ruland
and quantitated using a phosphatase substrate system (Kirkegaard
et al., 2001; Saijo et al., 2002; Su et al., 2002; Tan et al., and Perry Laboratories). Standard calibration curves were plotted
2001). Like the signalplex that is organized by INAD from the positive control sera, and the test serum titers were calcu-
within rhabdomeres on the surface of photoreceptor lated as an OD50 of these standard controls.
cells (Montell, 1999; Scott and Zuker, 1998), and the
hypothesized immunons generated by clustering twenty In Vitro Cell Stimulation Assays
or more antigen receptors with an average spacing of For B cell purification, red cell-depleted splenocytes were incubated
12 nm (Dintzis et al., 1976), these “immunosomes” may with biotinylated antibodies (PharMingen) to CD43 (S7) and Ly-76
(TER-119), and B cells were negatively selected using streptavidinbe much smaller than the 2000 nm supramolecular
MACS beads (Miltenyi Biotech) and MidiMACS separation columnsactivation complexes in T cells or patches and caps in
following the manufacturer’s instructions. Average purity was overB cells that can be detected by light microscopy. Large
97% B220 cells for both wild-type and mutant cells. T cells werecapped structures concentrating BCR and GM1 raft purified similarly after incubating cell suspensions with biotinylated
markers still form in unmodulated B cells (Figure 5C), antibodies against B220, CD11b, CD11c, F4/80, and Ly-76. Average
and it remains unclear how these very large structures 98% of lymphocytes were Thy1.2 after purification.
relate to the quality of signals and responses elicited. Goat anti-IgM F(ab)2 (Jackson ImmunoResearch), PMA (Sigma),
and ionomycin were used at 10 g/ml, 0.1 g/ml, and 1 M, respec-The early events in BCR signaling such as protein tyro-
tively, unless indicated otherwise. LPS (20 g/ml, Fluka), anti-CD40sine phosphorylation, elevation of intracellular calcium,
(10 g/ml 1C10), and recombinant IL-4 were used for assaying Bactivation of NFAT and ERK, precede formation of mi-
cell proliferation. T cells were stimulated with plate-coated anti-croscopically visible caps and occur normally in
TCR (H57-597) with or without 10 g/ml anti-CD28 (37.51). All cell
Carma-1 mutant B cells. These early events, which medi- stimulations were done in RPMI supplemented with 10% FCS, 10
ate both immunogenic and tolerogenic responses, de- mM HEPES, 55M -mercaptoethanol, 2 mM L-glutamine, 50 units/
pend on a distinct “early signalosome,” comprising Syk, ml penicillin/streptomycin, 1 mM sodium pyruvate, and 0.1 mM
nonessential amino acids. CFSE labeling was performed using theBtk, BLNK, Vav-1 and Vav-2, and PLC2 in B cells or
method of Lyons and Parish (1994). For DNA synthesis assays, 2 ZAP70, Tec and ILK, LAT, SLP76, Vav-1, and PLC in
105 cells in 200 l were cultured for 48 hr in flat bottom 96-wellT cells (Fruman et al., 2000; Turner and Billadeau, 2002;
culture plates, before pulsing with 1Ci [3H]thymidine for 8 hr. CFSE-Yablonski and Weiss, 2001). It will be important in future
labeled cells were cultured for 72 hr. For coculture experiments,
work to understand the dynamic relationships between Ly5a wild-type B6 splenocytes were mixed with an equal number of
early signalosomes (e.g., for calcium) that potentially Ly5b mutant splenocytes and treated as one sample. Intracellular
elicit immunity or tolerance, caps/synapse structures, calcium was measured on an LSR flow cytometer in splenocytes
from wild-type and mutant, mixed or individually, labeled with anti-and the selectively immunogenic assemblies that de-
B220, Indo-1 (Molecular Probes) and anti-Ly5a, or anti-Ly5b.pend on Carma-1. The selective role of Carma-1 in coor-
dinating immunogenic responses to antigen that we
demonstrate here makes it an especially attractive tar- Confocal Microscopy
Lymph node cells (20 106 cells/ml) were stained with cholera toxinget for immunosuppressive therapy.
(CT)-FITC and 2.4G2 on ice and gradually warmed to 37C. Cells
were then stimulated with biotinylated anti- light chain plus Strep-Experimental Procedures
tavidin-Cy3. Stimulation was stopped with ice-cold PBS/0.1% azide.
Cells were then spun onto 0.1% poly-L-Lysine-coated coverslipsGeneration, Mapping, and Typing of Mutation
and fixed in PBS/2% paraformaldehyde for 20 min. Slides wereMale C57BL/6 mice 8–15 weeks old were treated three times 1 week
apart with 100 mg/kg N-ethyl-N-nitrosourea (Sigma) prepared in observed with a Radiance 2000 confocal microscope (BioRad) using
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a sequential acquisition of the images at a 50 lines per second Dong, C., Yang, D.D., Tournier, C., Whitmarsh, A.J., Xu, J., Davis,
R.J., and Flavell, R.A. (2000). JNK is required for effector T-cellscanning speed.
function but not for T-cell activation. Nature 405, 91–94.
Western Blotting Dorado, B., Portoles, P., and Ballester, S. (1998). NF-kappaB in Th2
Cell lysates were subjected to SDS-PAGE and Western blotting cells: delayed and long-lasting induction through the TCR complex.
as described previously (Healy et al., 1997) using the following anti- Eur. J. Immunol. 28, 2234–2244.
sera: anti-phosphotyrosine (4G10, Upstate Biotechnology), anti-
Fanning, A.S., and Anderson, J.M. (1999). Protein modules as orga-phosphoERK1/2 (Cell Signaling Technology), anti-phophoJNK (G-7,
nizers of membrane structure. Curr. Opin. Cell Biol. 11, 432–439.Santa Cruz Biotechnology), anti-IB (Cell Signaling Technology),
Fruman, D.A., Satterthwaite, A.B., and Witte, O.N. (2000). Xid-likeanti-Bcl10 (331.3, Santa Cruz Biotechnology), anti--actin (AC-40,
phenotypes: a B cell signalosome takes shape. Immunity 13, 1–3.Sigma), and anti-mouse Carma-1 (Hara & Penninger). Densitometric
analyses were done using LAS-1000, Image Reader v1.3, and Image Gaide, O., Martinon, F., Micheau, O., Bonnet, D., Thome, M., and
Gauge v.3.4.6 (all from Fuji Photo Film). Tschopp, J. (2001). Carma1, a CARD-containing binding partner of
Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.
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